CoChat

Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes

Open access

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Myelodysplastic syndromes (MDS) are a group of disorders characterized by variable cytopenias and ineffective hematopoiesis. Hematopoietic stem cells (HSCs) and myeloid progenitors in MDS have not been extensively characterized. We transplanted purified human HSCs from MDS samples into immunodeficient mice and show that HSCs are the disease-initiating cells in MDS. We identify a recurrent loss of granulocyte-macrophage progenitors (GMPs) in the bone marrow of low risk MDS patients that can distinguish low risk MDS from clinical mimics, thus providing a simple diagnostic tool. The loss of GMPs is likely due to increased apoptosis and increased phagocytosis, the latter due to the up-regulation of cell surface calreticulin, a prophagocytic marker. Blocking calreticulin on low risk MDS myeloid progenitors rescues them from phagocytosis in vitro. However, in the high-risk refractory anemia with excess blasts (RAEB) stages of MDS, the GMP population is increased in frequency compared with normal, and myeloid progenitors evade phagocytosis due to up-regulation of CD47, an antiphagocytic marker. Blocking CD47 leads to the selective phagocytosis of this population. We propose that MDS HSCs compete with normal HSCs in the patients by increasing their frequency at the expense of normal hematopoiesis, that the loss of MDS myeloid progenitors by programmed cell death and programmed cell removal are, in part, responsible for the cytopenias, and that up-regulation of the "don't eat me" signal CD47 on MDS myeloid progenitors is an important transition step leading from low risk MDS to high risk MDS and, possibly, to acute myeloid leukemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1222861110

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 2

  1. R Brunning, et al., Myelodysplastic syndromes/neoplasms. WHO Classification of Tumours and Haematopoietic and Lymphoid Tissues, eds S Swerdlow, et al. (Intl Agency Res Cancer, Lyon, France) Vol 2 (2008).
  2. 10.1126/science.2971269 · doi:10.1126/science.2971269 · Paper page

Cited by

See all 278

Metadata

Authors
Pang, W. W., Pluvinage, J. V., Price, E. A., Sridhar, K., Arber, D. A., Greenberg, P. L., Schrier, S. L., Park, C. Y., & Weissman, I. L.
Affiliations
  • Institute for Stem Cell Biology and Regenerative Medicine (IN)
  • Stanford Medicine (US)
  • Departments of bPathology and
  • Memorial Sloan Kettering Cancer Center (US)
Venue
Proceedings of the National Academy of Sciences
Published
2013-02-06
Volume
110
Issue
8
Pages
3011-3016
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2126448969
Cited by
277
References
42
Citations by year
2026: 4 · 2025: 12 · 2024: 23 · 2023: 25 · 2022: 23 · 2021: 29 · 2020: 33 · 2019: 13 · 2018: 13 · 2017: 22 · 2016: 28 · 2015: 21 · 2014: 17 · 2013: 14
FWCI
19.14
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense (W81XWH-11-1-, W81XWH)
  • Leukemia and Lymphoma Society
  • National Institutes of Health (W81XWH)
  • National Institute on Aging (R01AG029124)
  • National Cancer Institute (R01 CA86065, K08CA1295470, R01CA086065, K08CA129547, P01CA139490, R01CA086017)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
Keywords
myelodysplastic syndrome, hematopoietic stem cells, myeloid progenitor cells, CFU-GM, calreticulin, CD47, phagocytosis, apoptosis, refractory anemia with excess blasts, acute myeloid leukemia, bone marrow transplantation, ineffective hematopoiesis
MeSH terms
Animals, Hematopoietic Stem Cells, Humans, Myelodysplastic Syndromes, Phagocytosis, Antigens, CD, In Situ Hybridization, Fluorescence, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. https://app.cochat.ai/papers/10.1073/pnas.1222861110
The paper
Pang, W. W., Pluvinage, J. V., Price, E. A., Sridhar, K., Arber, D. A., Greenberg, P. L., Schrier, S. L., Park, C. Y., & Weissman, I. L. (2013). Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1222861110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.